<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=7929355" created="25/10/2006" creator="Yo Shidahara"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>7929355</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term id="T1" lex="protease_inhibitor" sem="Organic_compound_other"><term id="A3" sem="Protein_family_or_group">Protease</term> inhibitors</term> block <term id="T2" lex="lipopolysaccharide_induction" sem="Other"><term id="T3" lex="lipopolysaccharide" sem="Lipid">lipopolysaccharide</term> induction</term> of <term id="T4" lex="gene_expression" sem="Other"><term id="A1" sem="DNA_domain_or_region">tissue factor gene</term> expression</term> in <term id="T5" lex="human_monocytic_cell" sem="Cell_natural">human monocytic cells</term> by preventing activation of <term id="T6" lex="c-Rel/p65_heterodimers" sem="Protein_complex"><term id="A2" sem="Protein_molecule">c-Rel</term>/<term id="T7" lex="p65" sem="Protein_molecule">p65</term> heterodimers</term>.</sentence>
<event KT="Other" id="E1">
<type class="Gene_expression"/>
<theme idref="A1"/>
<clue>Protease inhibitors block lipopolysaccharide induction of tissue factor gene <clueType>expression</clueType> <clueLoc>in human monocytic cells</clueLoc> by preventing activation of c-Rel/p65 heterodimers.</clue>
<comment>NER T4,T6 MOD</comment></event>
<event KT="Other" id="E2">
<type class="Positive_regulation"/>
<theme idref="E1"/>
<cause idref="T3"/>
<clue>Protease inhibitors block lipopolysaccharide <clueType>induction</clueType> <linkTheme>of</linkTheme> tissue factor gene expression in human monocytic cells by preventing activation of c-Rel/p65 heterodimers.</clue>
</event>
<event KT="Other" id="E3">
<type class="Positive_regulation"/>
<theme idref="T6"/>
<clue>Protease inhibitors block lipopolysaccharide induction of tissue factor gene expression in human monocytic cells by preventing <clueType>activation</clueType> <linkTheme>of</linkTheme> c-Rel/p65 heterodimers.</clue>
</event>
<event id="E4">
<type class="Negative_regulation"/>
<theme idref="E3"/>
<cause idref="T1"/>
<clue>Protease inhibitors <clueType>block</clueType> lipopolysaccharide induction of tissue factor gene expression in human monocytic cells <clueType>by preventing</clueType> activation of c-Rel/p65 heterodimers.</clue>
</event>
<event id="E5">
<type class="Negative_regulation"/>
<theme idref="E2"/>
<cause idref="E4"/>
<clue>Protease inhibitors <clueType>block</clueType> lipopolysaccharide induction of tissue factor gene expression in human monocytic cells <linkCause>by</linkCause> preventing activation of c-Rel/p65 heterodimers.</clue>
</event>
<event id="E6">
<type class="Negative_regulation"/>
<theme idref="A3"/>
<clue>Protease <clueType>inhibitors</clueType> block lipopolysaccharide induction of tissue factor gene expression in human monocytic cells by preventing activation of c-Rel/p65 heterodimers.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2"><term id="T8" lex="Tissue_factor" sem="Protein_family_or_group">Tissue factor</term> (<term id="T9" lex="TF" sem="Protein_family_or_group">TF</term>) is expressed rapidly by <term id="T10" lex="human_monocyte" sem="Cell_natural">human monocytes</term> exposed to <term id="T11" lex="bacterial_endotoxin" sem="Protein_family_or_group">bacterial endotoxin</term> (<term id="T12" lex="lipopolysaccharide" sem="Lipid">lipopolysaccharide</term>, or <term id="T13" lex="LPS" sem="Lipid">LPS</term>).</sentence>
<event KT="Other" id="E7">
<type class="Gene_expression"/>
<theme idref="T9"/>
<clue>Tissue factor (TF) is <clueType>expressed</clueType> rapidly <clueLoc>by human monocytes</clueLoc> exposed to bacterial endotoxin (lipopolysaccharide, or LPS).</clue>
</event>
<event KT="Fact" Manner="High" id="E8">
<type class="Positive_regulation"/>
<theme idref="E7"/>
<cause idref="T11"/>
<clue>Tissue factor (TF) is expressed <clueTime><clueManner>rapidly</clueManner></clueTime> by human monocytes <linkCause>exposed to</linkCause> bacterial endotoxin (lipopolysaccharide, or LPS).</clue>
<comment>NO CLUETYPE</comment></event>
<event KT="Fact" Manner="High" id="E108">
<type class="Positive_regulation"/>
<theme idref="E7"/>
<cause idref="T12"/>
<clue>Tissue factor (TF) is expressed <clueTime><clueManner>rapidly</clueManner></clueTime> by human monocytes <linkCause>exposed to</linkCause> bacterial endotoxin (lipopolysaccharide, or LPS).</clue>
<comment>NO CLUETYPE</comment></event>
<event KT="Fact" Manner="High" id="E208">
<type class="Positive_regulation"/>
<theme idref="E7"/>
<cause idref="T13"/>
<clue>Tissue factor (TF) is expressed <clueTime><clueManner>rapidly</clueManner></clueTime> by human monocytes <linkCause>exposed to</linkCause> bacterial endotoxin (lipopolysaccharide, or LPS).</clue>
<comment>NO CLUETYPE</comment></event>
<sentence id="S3">Transcriptional regulation is mediated by binding of <term id="T14" lex="c-Rel/p65_heterodimers" sem="Protein_complex"><term id="T15" lex="c-Rel" sem="Protein_molecule">c-Rel</term><term id="T16" lex="p65" sem="Protein_molecule">/p65</term> heterodimers</term> to a <term id="T17" lex="kappa_B-like_site" sem="DNA_domain_or_region">kappa B-like site</term> in the <term id="T18" lex="TF_promoter" sem="DNA_domain_or_region"><term id="T19" lex="TF" sem="Protein_family_or_group">TF</term> promoter</term>.</sentence>
<event KT="Other" id="E9">
<type class="Binding"/>
<theme idref="T14"/>
<theme idref="T17"/>
<clue>Transcriptional regulation is mediated by <clueType>binding</clueType> <linkTheme>of</linkTheme> c-Rel/p65 heterodimers <linkTheme>to</linkTheme> a kappa B-like site in the TF promoter.</clue>
</event>
<event KT="Other" id="E10">
<type class="Transcription"/>
<theme idref="T19"/>
<clue><clueType>Transcriptional</clueType> regulation is mediated by binding of c-Rel/p65 heterodimers to a kappa B-like site in the TF promoter.</clue>
<comment>NO COREFTHEME</comment></event>
<event KT="Fact" id="E11">
<type class="Regulation"/>
<theme idref="E10"/>
<cause idref="E9"/>
<clue>Transcriptional <clueType>regulation</clueType> is <linkCause>mediated by</linkCause> binding of c-Rel/p65 heterodimers to a kappa B-like site in the TF promoter.</clue>
</event>
<sentence id="S4">Nuclear translocation of <term id="T20" lex="cytosolic_c-Rel/p65_heterodimer" sem="Protein_complex">cytosolic <term id="A4" sem="Protein_molecule">c-Rel</term>/<term id="T21" lex="p65" sem="Protein_molecule">p65</term> heterodimers</term> and other members of the <term id="T22" lex="NF-kappa_B/Rel_family" sem="Protein_family_or_group"><term id="T23" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term>/Rel family</term> requires dissociation and proteolytic degradation of the <term id="T24" lex="inhibitor_protein" sem="Protein_family_or_group">inhibitor protein</term>, <term id="T25" lex="I_kappa_B_alpha" sem="Protein_molecule">I kappa B alpha</term>.</sentence>
<event KT="Other" id="E12">
<type class="Localization"/>
<theme idref="T20"/>
<clue><clueLoc>Nuclear</clueLoc> <clueType>translocation</clueType> <linkTheme>of</linkTheme> cytosolic c-Rel/p65 heterodimers and other members of the NF-kappa B/Rel family requires dissociation and proteolytic degradation of the inhibitor protein, I kappa B alpha.</clue>
</event>
<event KT="Other" id="E13">
<type class="Localization"/>
<theme idref="T22"/>
<clue><clueLoc>Nuclear</clueLoc> <clueType>translocation</clueType> <linkTheme>of</linkTheme> cytosolic c-Rel/p65 heterodimers and other members of the NF-kappa B/Rel family requires dissociation and proteolytic degradation of the inhibitor protein, I kappa B alpha.</clue>
</event>
<event KT="Other" id="E14">
<type/>
<theme idref="T25"/>
<theme idref="T20"/>
<clue>Nuclear translocation of cytosolic c-Rel/p65 heterodimers and other members of the NF-kappa B/Rel family requires <clueType>dissociation</clueType> and proteolytic degradation <linkTheme>of</linkTheme> the inhibitor protein, I kappa B alpha.</clue>
<comment>SOO, NO COREFTEHEME FOR T20</comment></event>
<event KT="Other" id="E114">
<type/>
<theme idref="T25"/>
<theme idref="T22"/>
<clue>Nuclear translocation of cytosolic c-Rel/p65 heterodimers and other members of the NF-kappa B/Rel family requires <clueType>dissociation</clueType> and proteolytic degradation <linkTheme>of</linkTheme> the inhibitor protein, I kappa B alpha.</clue>
<comment>SOO, NO COREFTEHEME FOR T22</comment></event>
<event KT="Other" id="E15">
<type class="Protein_catabolism"/>
<theme idref="T25"/>
<clue>Nuclear translocation of cytosolic c-Rel/p65 heterodimers and other members of the NF-kappa B/Rel family requires dissociation and <clueType>proteolytic degradation</clueType> <linkTheme>of</linkTheme> the inhibitor protein, I kappa B alpha.</clue>
</event>
<event KT="Fact" id="E16">
<type class="Positive_regulation"/>
<theme idref="E12"/>
<cause idref="E14"/>
<clue>Nuclear translocation of cytosolic c-Rel/p65 heterodimers and other members of the NF-kappa B/Rel family <clueType>requires</clueType> dissociation and proteolytic degradation of the inhibitor protein, I kappa B alpha.</clue>
</event>
<event KT="Fact" id="E17">
<type class="Positive_regulation"/>
<theme idref="E13"/>
<cause idref="E114"/>
<clue>Nuclear translocation of cytosolic c-Rel/p65 heterodimers and other members of the NF-kappa B/Rel family <clueType>requires</clueType> dissociation and proteolytic degradation of the inhibitor protein, I kappa B alpha.</clue>
</event>
<event KT="Fact" id="E18">
<type class="Positive_regulation"/>
<theme idref="E12"/>
<cause idref="E15"/>
<clue>Nuclear translocation of cytosolic c-Rel/p65 heterodimers and other members of the NF-kappa B/Rel family <clueType>requires</clueType> dissociation and proteolytic degradation of the inhibitor protein, I kappa B alpha.</clue>
</event>
<event KT="Fact" id="E19">
<type class="Positive_regulation"/>
<theme idref="E13"/>
<cause idref="E15"/>
<clue>Nuclear translocation of cytosolic c-Rel/p65 heterodimers and other members of the NF-kappa B/Rel family <clueType>requires</clueType> dissociation and proteolytic degradation of the inhibitor protein, I kappa B alpha.</clue>
</event>
<sentence id="S5">The <term id="A6" sem="Organic_compound_other"><term id="A7" sem="Protein_family_or_group">protease</term> inhibitors</term> <term id="T26" lex="N_alpha-tosylphenylalanyl_chloromethyl_ketone" sem="Organic_compound_other">N alpha-tosylphenylalanyl chloromethyl ketone</term> (<term id="T27" lex="TPCK" sem="Organic_compound_other">TPCK</term>) and <term id="T28" lex="N_alpha-tosyl-L-lysine_chloromethyl_ketone" sem="Organic_compound_other">N alpha-tosyl-L-lysine chloromethyl ketone</term> (<term id="T29" lex="TLCK" sem="Organic_compound_other">TLCK</term>) block activation of <term id="T30" lex="NF-kappa_B/Rel_protein" sem="Protein_family_or_group"><term id="T31" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term>/<term id="A5" sem="Protein_family_or_group">Rel</term> proteins</term> by preventing degradation of <term id="T32" lex="I_kappa_B_alpha" sem="Protein_molecule">I kappa B alpha</term>.</sentence>
<event KT="Other" id="E20">
<type class="Positive_regulation"/>
<theme idref="T30"/>
<clue>The protease inhibitors N alpha-tosylphenylalanyl chloromethyl ketone (TPCK) and N alpha-tosyl-L-lysine chloromethyl ketone (TLCK) block <clueType>activation</clueType> <linkTheme>of</linkTheme> NF-kappa B/Rel proteins by preventing degradation of I kappa B alpha.</clue>
<comment>NER T30 MOD</comment></event>
<event KT="Other" id="E21">
<type class="Protein_catabolism"/>
<theme idref="T32"/>
<clue>The protease inhibitors N alpha-tosylphenylalanyl chloromethyl ketone (TPCK) and N alpha-tosyl-L-lysine chloromethyl ketone (TLCK) block activation of NF-kappa B/Rel proteins by preventing <clueType>degradation</clueType> <linkTheme>of</linkTheme> I kappa B alpha.</clue>
</event>
<event id="E22">
<type class="Negative_regulation"/>
<theme idref="E21"/>
<cause idref="T27"/>
<clue>The protease inhibitors N alpha-tosylphenylalanyl chloromethyl ketone (TPCK) and N alpha-tosyl-L-lysine chloromethyl ketone (TLCK) block activation of NF-kappa B/Rel proteins by <clueType>preventing</clueType> degradation of I kappa B alpha.</clue>
</event>
<event id="E23">
<type class="Negative_regulation"/>
<theme idref="E21"/>
<cause idref="T29"/>
<clue>The protease inhibitors N alpha-tosylphenylalanyl chloromethyl ketone (TPCK) and N alpha-tosyl-L-lysine chloromethyl ketone (TLCK) block activation of NF-kappa B/Rel proteins by <clueType>preventing</clueType> degradation of I kappa B alpha.</clue>
</event>
<event id="E24">
<type class="Negative_regulation"/>
<theme idref="E20"/>
<cause idref="E22"/>
<clue>The protease inhibitors N alpha-tosylphenylalanyl chloromethyl ketone (TPCK) and N alpha-tosyl-L-lysine chloromethyl ketone (TLCK) <clueType>block</clueType> activation of NF-kappa B/Rel proteins <linkCause>by</linkCause> preventing degradation of I kappa B alpha.</clue>
</event>
<event id="E25">
<type class="Negative_regulation"/>
<theme idref="E20"/>
<cause idref="E23"/>
<clue>The protease inhibitors N alpha-tosylphenylalanyl chloromethyl ketone (TPCK) and N alpha-tosyl-L-lysine chloromethyl ketone (TLCK) <clueType>block</clueType> activation of NF-kappa B/Rel proteins <linkCause>by</linkCause> preventing degradation of I kappa B alpha.</clue>
</event>
<event id="E26">
<type class="Negative_regulation"/>
<theme idref="A7"/>
<cause idref="T27"/>
<clue>The protease <clueType>inhibitors</clueType> N alpha-tosylphenylalanyl chloromethyl ketone (TPCK) and N alpha-tosyl-L-lysine chloromethyl ketone (TLCK) block activation of NF-kappa B/Rel proteins by preventing degradation of I kappa B alpha.</clue>
</event>
<event id="E27">
<type class="Negative_regulation"/>
<theme idref="A7"/>
<cause idref="T29"/>
<clue>The protease <clueType>inhibitors</clueType> N alpha-tosylphenylalanyl chloromethyl ketone (TPCK) and N alpha-tosyl-L-lysine chloromethyl ketone (TLCK) block activation of NF-kappa B/Rel proteins by preventing degradation of I kappa B alpha.</clue>
</event>
<sentence id="S6">To determine if <term id="T33" lex="TPCK" sem="Organic_compound_other">TPCK</term> and <term id="T34" lex="TLCK" sem="Organic_compound_other">TLCK</term> inhibited <term id="T35" lex="LPS_induction" sem="Other"><term id="T36" lex="LPS" sem="Lipid">LPS</term> induction</term> of <term id="T37" lex="TF_expression" sem="Other"><term id="T38" lex="TF" sem="Protein_family_or_group">TF</term> expression</term>, freshly isolated <term id="T39" lex="human_monocyte" sem="Cell_natural">human monocytes</term> and <term id="T40" lex="monocytic_THP-1_cell" sem="Cell_cultured">monocytic THP-1 cells</term> were pretreated with these inhibitors for 30 min before <term id="T41" lex="LPS_stimulation" sem="Other"><term id="T42" lex="LPS" sem="Lipid">LPS</term> stimulation</term>.</sentence>
<event KT="Other" id="E28">
<type class="Gene_expression"/>
<theme idref="T38"/>
<clue>To determine if TPCK and TLCK inhibited LPS induction of TF <clueType>expression</clueType>, freshly isolated human monocytes and monocytic THP-1 cells were pretreated with these inhibitors for 30 min before LPS stimulation.</clue>
</event>
<event KT="Other" id="E29">
<type class="Positive_regulation"/>
<theme idref="E28"/>
<cause idref="T36"/>
<clue>To determine if TPCK and TLCK inhibited LPS <clueType>induction</clueType> <linkTheme>of</linkTheme> TF expression, freshly isolated human monocytes and monocytic THP-1 cells were pretreated with these inhibitors for 30 min before LPS stimulation.</clue>
</event>
<event KT="Investigation" id="E30" uncertainty="doubtful">
<type class="Negative_regulation"/>
<theme idref="E29"/>
<cause idref="T33"/>
<clue><clueKT>To determine</clueKT> if TPCK and TLCK <clueType>inhibited</clueType> LPS induction of TF expression, freshly isolated human monocytes and monocytic THP-1 cells were pretreated with these inhibitors for 30 min before LPS stimulation.</clue>
</event>
<event KT="Investigation" id="E31" uncertainty="doubtful">
<type class="Negative_regulation"/>
<theme idref="E29"/>
<cause idref="T34"/>
<clue><clueKT>To determine</clueKT> if TPCK and TLCK <clueType>inhibited</clueType> LPS induction of TF expression, freshly isolated human monocytes and monocytic THP-1 cells were pretreated with these inhibitors for 30 min before LPS stimulation.</clue>
</event>
<event id="E131">
<type class="Physiological_process"/>
<theme idref="T39"/>
<cause idref="T42"/>
<clue>To determine if TPCK and TLCK inhibited LPS induction of TF expression, freshly isolated human monocytes and monocytic THP-1 cells were pretreated with these inhibitors for 30 min before LPS <clueType>stimulation</clueType>.</clue>
</event>
<event id="E132">
<type class="Physiological_process"/>
<theme idref="T40"/>
<cause idref="T42"/>
<clue>To determine if TPCK and TLCK inhibited LPS induction of TF expression, freshly isolated human monocytes and monocytic THP-1 cells were pretreated with these inhibitors for 30 min before LPS <clueType>stimulation</clueType>.</clue>
</event>
<sentence id="S7">Both <term id="T43" lex="TPCK" sem="Organic_compound_other">TPCK</term> and <term id="T44" lex="TLCK_inhibited_LPS_induction" sem="Other"><term id="T45" lex="TLCK" sem="Organic_compound_other">TLCK</term> inhibited <term id="T46" lex="LPS" sem="Lipid">LPS</term> induction</term> of <term id="T47" lex="TF_protein" sem="Protein_molecule">TF protein</term>, <term id="T48" lex="TF_mRNA" sem="RNA_molecule">TF mRNA</term> and <term id="T49" lex="TF_promoter_activity" sem="Other"><term id="T50" lex="TF" sem="DNA_domain_or_region">TF promoter</term> activity</term> in a dose-dependent manner.</sentence>
<event KT="Other" id="E32">
<type class="Positive_regulation"/>
<theme idref="T47"/>
<cause idref="T46"/>
<clue>Both TPCK and TLCK inhibited LPS <clueType>induction</clueType> <linkTheme>of</linkTheme> TF protein, TF mRNA and TF promoter activity in a dose-dependent manner.</clue>
<comment>NER T50 MOD</comment></event>
<event KT="Other" id="E33">
<type class="Positive_regulation"/>
<theme idref="T48"/>
<cause idref="T46"/>
<clue>Both TPCK and TLCK inhibited LPS <clueType>induction</clueType> <linkTheme>of</linkTheme> TF protein, TF mRNA and TF promoter activity in a dose-dependent manner.</clue>
</event>
<event KT="Other" id="E34">
<type class="Positive_regulation"/>
<theme idref="T50"/>
<cause idref="T46"/>
<clue>Both TPCK and TLCK inhibited LPS <clueType>induction</clueType> <linkTheme>of</linkTheme> TF protein, TF mRNA and TF promoter activity in a dose-dependent manner.</clue>
</event>
<event id="E35">
<type class="Negative_regulation"/>
<theme idref="E32"/>
<cause idref="T43"/>
<clue>Both TPCK and TLCK <clueType>inhibited</clueType> LPS induction of TF protein, TF mRNA and TF promoter activity in a dose-dependent manner.</clue>
</event>
<event id="E36">
<type class="Negative_regulation"/>
<theme idref="E33"/>
<cause idref="T43"/>
<clue>Both TPCK and TLCK <clueType>inhibited</clueType> LPS induction of TF protein, TF mRNA and TF promoter activity in a dose-dependent manner.</clue>
</event>
<event id="E37">
<type class="Negative_regulation"/>
<theme idref="E34"/>
<cause idref="T43"/>
<clue>Both TPCK and TLCK <clueType>inhibited</clueType> LPS induction of TF protein, TF mRNA and TF promoter activity in a dose-dependent manner.</clue>
</event>
<event id="E38">
<type class="Negative_regulation"/>
<theme idref="E32"/>
<cause idref="T45"/>
<clue>Both TPCK and TLCK <clueType>inhibited</clueType> LPS induction of TF protein, TF mRNA and TF promoter activity in a dose-dependent manner.</clue>
</event>
<event id="E39">
<type class="Negative_regulation"/>
<theme idref="E33"/>
<cause idref="T45"/>
<clue>Both TPCK and TLCK <clueType>inhibited</clueType> LPS induction of TF protein, TF mRNA and TF promoter activity in a dose-dependent manner.</clue>
</event>
<event id="E40">
<type class="Negative_regulation"/>
<theme idref="E34"/>
<cause idref="T45"/>
<clue>Both TPCK and TLCK <clueType>inhibited</clueType> LPS induction of TF protein, TF mRNA and TF promoter activity in a dose-dependent manner.</clue>
</event>
<sentence id="S8">These inhibitors specifically prevented degradation of <term id="T52" lex="I_kappa_B_alpha" sem="Protein_molecule">I kappa B alpha</term> and <term id="T53" lex="nuclear_translocation" sem="Other">nuclear translocation</term> of <term id="T54" lex="c-Rel/p65_heterodimer" sem="Protein_complex"><term id="T55" lex="c-Rel" sem="Protein_molecule">c-Rel</term>/<term id="T56" lex="p65" sem="Protein_molecule">p65</term> heterodimers</term>.</sentence>
<event KT="Other" id="E41">
<type class="Protein_catabolism"/>
<theme idref="T52"/>
<clue>These inhibitors specifically prevented <clueType>degradation</clueType> <linkTheme>of</linkTheme> I kappa B alpha and nuclear translocation of c-Rel/p65 heterodimers.</clue>
<comment>NER T56 MOD</comment></event>
<event KT="Other" id="E42">
<type class="Localization"/>
<theme idref="T54"/>
<clue>These inhibitors specifically prevented degradation of I kappa B alpha and <clueLoc>nuclear</clueLoc> <clueType>translocation</clueType> <linkTheme>of</linkTheme> c-Rel/p65 heterodimers.</clue>
</event>
<event id="E43">
<type class="Negative_regulation"/>
<theme idref="E41"/>
<cause idref="T43"/>
<clue><corefCause>These inhibitors</corefCause> specifically <clueType>prevented</clueType> degradation of I kappa B alpha and nuclear translocation of c-Rel/p65 heterodimers.</clue>
</event>
<event id="E44">
<type class="Negative_regulation"/>
<theme idref="E42"/>
<cause idref="T43"/>
<clue><corefCause>These inhibitors</corefCause> specifically <clueType>prevented</clueType> degradation of I kappa B alpha and nuclear translocation of c-Rel/p65 heterodimers.</clue>
</event>
<event id="E45">
<type class="Negative_regulation"/>
<theme idref="E41"/>
<cause idref="T45"/>
<clue><corefCause>These inhibitors</corefCause> specifically <clueType>prevented</clueType> degradation of I kappa B alpha and nuclear translocation of c-Rel/p65 heterodimers.</clue>
</event>
<event id="E46">
<type class="Negative_regulation"/>
<theme idref="E42"/>
<cause idref="T45"/>
<clue><corefCause>These inhibitors</corefCause> specifically <clueType>prevented</clueType> degradation of I kappa B alpha and nuclear translocation of c-Rel/p65 heterodimers.</clue>
</event>
<sentence id="S9">In contrast, <term id="T57" lex="TPCK" sem="Organic_compound_other">TPCK</term> and <term id="T58" lex="TLCK" sem="Organic_compound_other">TLCK</term> did not block induction of an <term id="A8" sem="DNA_domain_or_region"><term id="T59" lex="immediate-early_gene" sem="DNA_domain_or_region">immediate-early gene</term> encoding the <term id="T60" lex="transcription_factor" sem="Protein_family_or_group">transcription factor</term>, <term id="T61" lex="Egr-1" sem="Protein_molecule">Egr-1</term></term>.</sentence>
<event id="E47">
<type class="Positive_regulation"/>
<theme idref="A8"/>
<clue>In contrast, TPCK and TLCK did not block <clueType>induction</clueType> <linkTheme>of</linkTheme> an immediate-early gene encoding the transcription factor, Egr-1.</clue>
<comment>TPS A8</comment></event>
<event Polarity="Negative" assertion="non-exist" id="E48">
<type class="Negative_regulation"/>
<theme idref="E47"/>
<cause idref="T57"/>
<clue>In contrast, TPCK and TLCK did <cluePolarity>not</cluePolarity> <clueType>block</clueType> induction of an immediate-early gene encoding the transcription factor, Egr-1.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E49">
<type class="Negative_regulation"/>
<theme idref="E47"/>
<cause idref="T58"/>
<clue>In contrast, TPCK and TLCK did <cluePolarity>not</cluePolarity> <clueType>block</clueType> induction of an immediate-early gene encoding the transcription factor, Egr-1.</clue>
</event>
<sentence id="S10">Taken together, these data indicated that inhibiting nuclear translocation of <term id="T62" lex="c-Rel/p65_heterodimer" sem="Protein_complex"><term id="T63" lex="c-Rel" sem="Protein_molecule">c-Rel</term><term id="T64" lex="p65" sem="Protein_molecule">/p65</term> heterodimers</term> prevented <term id="T65" lex="LPS_induction" sem="Other"><term id="T66" lex="LPS" sem="Lipid">LPS</term> induction</term> of <term id="T67" lex="TF_gene_transcription" sem="Other"><term id="T68" lex="TF" sem="DNA_domain_or_region">TF gene</term> transcription</term> in <term id="T69" lex="monocytic_cell" sem="Cell_natural">monocytic cells</term>.</sentence>
<event KT="Other" id="E50">
<type class="Localization"/>
<theme idref="T62"/>
<clue>Taken together, these data indicated that inhibiting <clueLoc>nuclear</clueLoc> <clueType>translocation</clueType> <linkTheme>of</linkTheme> c-Rel/p65 heterodimers prevented LPS induction of TF gene transcription in monocytic cells.</clue>
<comment>NER T68 MOD</comment></event>
<event KT="Other" id="E51">
<type class="Negative_regulation"/>
<theme idref="E50"/>
<clue>Taken together, these data indicated that <clueType>inhibiting</clueType> nuclear translocation of c-Rel/p65 heterodimers prevented LPS induction of TF gene transcription in monocytic cells.</clue>
</event>
<event KT="Other" id="E52">
<type class="Transcription"/>
<theme idref="T68"/>
<clue>Taken together, these data indicated that inhibiting nuclear translocation of c-Rel/p65 heterodimers prevented LPS induction of TF gene <clueType>transcription</clueType> <clueLoc>in monocytic cells</clueLoc>.</clue>
</event>
<event KT="Other" id="E53">
<type class="Positive_regulation"/>
<theme idref="E52"/>
<cause idref="T66"/>
<clue>Taken together, these data indicated that inhibiting nuclear translocation of c-Rel/p65 heterodimers prevented LPS <clueType>induction</clueType> <linkTheme>of</linkTheme> TF gene transcription in monocytic cells.</clue>
</event>
<event CL="L2" KT="Analysis" id="E54">
<type class="Negative_regulation"/>
<theme idref="E53"/>
<cause idref="E51"/>
<clue>Taken together, these data <clueKT><clueCL>indicated</clueCL></clueKT> that inhibiting nuclear translocation of c-Rel/p65 heterodimers <clueType>prevented</clueType> LPS induction of TF gene transcription in monocytic cells.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
